Menopause-Associated Depression: Impact of Oxidative Stress and Neuroinflammation on the Central Nervous System—A Review

Gengfan Liang,Audrey Siew Foong Kow,Rohana Yusof,Chau Ling Tham,Yu-Cheng Ho,Ming Tatt Lee

DOI: https://doi.org/10.3390/biomedicines12010184

IF: 4.757

2024-01-16

Biomedicines

Abstract:Perimenopausal depression, occurring shortly before or after menopause, is characterized by symptoms such as emotional depression, anxiety, and stress, often accompanied by endocrine dysfunction, particularly hypogonadism and senescence. Current treatments for perimenopausal depression primarily provide symptomatic relief but often come with undesirable side effects. The development of agents targeting the specific pathologies of perimenopausal depression has been relatively slow. The erratic fluctuations in estrogen and progesterone levels during the perimenopausal stage expose women to the risk of developing perimenopausal-associated depression. These hormonal changes trigger the production of proinflammatory mediators and induce oxidative stress, leading to progressive neuronal damage. This review serves as a comprehensive overview of the underlying mechanisms contributing to perimenopausal depression. It aims to shed light on the complex relationship between perimenopausal hormones, neurotransmitters, brain-derived neurotrophic factors, chronic inflammation, oxidative stress, and perimenopausal depression. By summarizing the intricate interplay between hormonal fluctuations, neurotransmitter activity, brain-derived neurotrophic factors, chronic inflammation, oxidative stress, and perimenopausal depression, this review aims to stimulate further research in this field. The hope is that an increased understanding of these mechanisms will pave the way for the development of more effective therapeutic targets, ultimately reducing the risk of depression during the menopausal stage for the betterment of psychological wellbeing.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the occurrence mechanism of Menopause - Associated Depression (MAD), especially the influence of oxidative stress and neuroinflammation on the central nervous system. Specifically, the paper explores the following aspects:

1. **The relationship between hormonal changes and depression**: The paper discusses in detail the role of estrogen in menopausal depression, especially its importance in regulating neurotransmitter systems (such as the serotonin, norepinephrine and dopamine systems). Fluctuations and declines in estrogen levels may lead to weakened neuroprotective effects, thus having a negative psychological impact on some women.

2. **The decrease in brain - derived neurotrophic factor (BDNF)**: The paper points out that BDNF plays a crucial role in memory formation and the plasticity of the hippocampus. Studies have shown that the decrease in BDNF levels is related to estrogen deficiency after bilateral oophorectomy, and estrogen can increase the expression and release of BDNF through estrogen receptor β.

3. **The dysregulation of the hypothalamic - pituitary - adrenal axis (HPA axis)**: The paper emphasizes the close relationship between the over - activity of the HPA axis and anxiety, depression and cognitive dysfunction. Estrogen deficiency can weaken the regulation of the HPA axis on external stress, leading to over - activation of the HPA axis.

4. **The role of neuroinflammation**: The paper indicates that chronic inflammation and bioenergetic defects during menopause are important factors connecting genetic risk factors and various neurodegenerative diseases. The decline in estrogen levels is related to the increase in pro - inflammatory cytokines (such as IL - 8 and TNF - α), and the increase in these cytokines may promote the development of neuroinflammation.

Through a comprehensive analysis of these mechanisms, the paper aims to reveal the complex pathophysiological process of menopausal depression and provide a theoretical basis for the development of more effective treatment strategies. It is hoped that these studies can provide new ideas for reducing the risk of depression in menopausal women and improving mental health.